Zuellig Pharma Korea accused of unprofitable wholesaler margin policy

Published: 2004-09-08 07:00:00

Updated: 2004-09-08 07:00:00

A major row is brewing over the recent Zuellig Pharma Korea's wholesaler margin policy after President Christian Stoeckling said that the current appropriate margin level will not increase or decrease.

The president's remarks brought an immediate hostile response from the domestic wholesaling ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK